Evidence map›Paper›PMID 39187346›Full record

ArticleIn vivo (Athens, Greece)

Thyroiditis and Thyroid Cancer: Bioinformatics Analysis of Gene Expression Data.

Szu-I Yu, Yu-Kang Chang, Meei-Ling Sheu, Yao-Hsien Tseng

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Szu-I YuInstitute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan, R.O.C.
Yu-Kang ChangDepartment of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, R.O.C.
Meei-Ling SheuInstitute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan, R.O.C.; mlsheu@nchu.edu.tw.
Yao-Hsien TsengDepartment of Endocrinology and Metabolism, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, R.O.C. dr1080118@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimHashimoto thyroiditis (HT) association with thyroid lymphoma is well established; however, the association with papillary thyroid cancer (PTC) is still unclear. Thyroid cancer incidence has shown an increasing trend in recent years. It is characterized by slow growth, making it generally amenable to successful treatment. MATERIALS AND

methodsWe aimed to identify genes considered as promising biomarkers of the progression from thyroiditis to thyroid cancer in public gene expression datasets.

resultsWe identified 70 differentially expressed genes (DEGs) and used them to prioritize biological risk genes for thyroiditis and thyroid cancer. Statistics and a scoring system based on six functional annotations of significant biological impact identified four genes of interest: CXCR4, IL6ST, PPARG and TP53. Kaplan-Meier plots were used to assess the expression levels related to overall survival. Furthermore, a manual bibliographic search was carried out for each gene, and a protein-protein interaction (PPI) network was built to verify their known associations.

conclusionThe results showed that all four genes (CXCR4, IL6ST, PPARG, TP53) were highly relevant to thyroiditis and thyroid cancer, thus making them worthy of further investigation to understand their relationship with these two diseases.

Indexed as

Computational BiologyGene Expression ProfilingThyroid NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansKaplan-Meier EstimatePrognosisProtein Interaction MapsThyroiditisTranscriptomeBiomarkers, TumorPPARGPPARgamma genethyroid cancerThyroiditisTP53 bioinformatics

Identifiers

PMID39187346
PMCPMC11363792

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.